Every treatment we track, side by side. Same information, same order, every time.
ticagrelor
Antiplatelet therapy after ACS / selected cardiovascular risk contexts
mavacamten
Obstructive hypertrophic cardiomyopathy
ivabradine
Heart failure / heart rate reduction
apixaban
Anticoagulant for AFib and VTE
sacubitril/valsartan
Heart failure
dapagliflozin
Type 2 diabetes, heart failure, CKD
empagliflozin
inclisiran
LDL-C lowering
pitavastatin
Cholesterol lowering
aspirin 81 mg
Antiplatelet therapy in selected patients; not casual primary prevention
bempedoic acid
bempedoic acid/ezetimibe
nicotine patch
Smoking cessation support
nicotine gum/lozenge
Smoking cessation support that can reduce cardiovascular risk
macitentan
Pulmonary arterial hypertension
alirocumab
evolocumab
LDL-C lowering and ASCVD risk
edoxaban
Anticoagulant
acetaminophen
Pain/fever option often used when avoiding NSAIDs
icosapent ethyl
Triglycerides and cardiovascular risk reduction in selected patients
vericiguat
tafamidis
ATTR cardiomyopathy
sotatercept-csrk
rivaroxaban